Schafer Joshua
SEC CIK 1945557 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | CCO, EVP, Bus. Development | 62.3K | $17.2K | $208.8K | 8 | 2023-03-14 | 2026-02-03 |
Most active insiders at ZVRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| 2 | Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| 3 | Watton Corey Michael | Dir | — | $138.4K |
| 4 | Schafer Joshua | CCO | — | $126.3K |
| 5 | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| 6 | Quartel Adrian W | Chief Medical Off | — | $40.0K |
| 7 | Bode John B | Dir | — | — |
| 8 | Clifton R. LaDuane | Former CFO, Treas | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-04 | 2026-02-03 | ZVRA | ZEVRA THERAPEUTICS, INC. | Schafer Joshua | CCO | S - Sale | $9.19 | -10.5K | 62.3K | -14% | -$96.5K | |
| DM | 2026-02-02 | 2026-01-30+ | ZVRA | ZEVRA THERAPEUTICS, INC. | Schafer Joshua | CCO | M - OptEx | — | +46.7K | 72.8K | +179% | — |
| D | 2026-02-02 | 2026-01-30 | ZVRA | ZEVRA THERAPEUTICS, INC. | Schafer Joshua | CCO | S - Sale+OE | $8.83 | -3,375 | 37.4K | -8% | -$29.8K |
| 2025-02-14 | 2025-02-13 | ZVRA | ZEVRA THERAPEUTICS, INC. | Schafer Joshua | CCO, EVP, Bus. Development | S - Sale | $7.86 | -10.5K | 29.5K | -26% | -$82.5K | |
| D | 2025-02-03 | 2025-01-31 | ZVRA | ZEVRA THERAPEUTICS, INC. | Schafer Joshua | CCO, EVP, Bus. Development | M - OptEx | — | +35.3K | 40.0K | +759% | — |
| 2023-09-06 | 2023-09-05 | ZVRA | ZEVRA THERAPEUTICS, INC. | Schafer Joshua | CCO, EVP, Bus. Development | P - Purchase | $5.13 | +500 | 3,500 | +17% | +$2,565 | |
| 2023-06-30 | 2023-05-19 | ZVRA | ZEVRA THERAPEUTICS, INC. | Schafer Joshua | CCO, EVP, Bus. Development | P - Purchase | $5.42 | +1,000 | 3,000 | +50% | +$5,420 | |
| 2023-03-15 | 2023-03-14 | ZVRA | ZEVRA THERAPEUTICS, INC. | Schafer Joshua | CCO, EVP, Bus. Development | P - Purchase | $4.61 | +2,000 | 2,000 | New | +$9,220 |
Purchase Sale Sale after option exercise All abbreviations